London-based venture capital firm, 4BIO Capital, specializing in advanced therapies and emerging technologies, has made significant announcements regarding its Advisory Board and internal promotions.
These strategic moves underscore the firm’s commitment to bolstering its expertise and leadership team.
Advisory Board Appointments
The firm welcomes Abbas Hussain and Leszek Lisowski, PhD MBA, to its Advisory Board.
Abbas Hussain, a veteran in the biopharmaceutical industry with over 30 years of experience, brings a wealth of knowledge, having served as the CEO of Vifor Pharma and held pivotal roles at GSK and Eli Lilly.
Leszek Lisowski, a renowned vectorology expert, has over two decades of experience in developing and manufacturing viral vectors.
His contributions include co-founding LogicBio Therapeutics and establishing gene therapy companies in Australia.
Promotion to Principal
In a notable internal promotion, Dr. Natalie Johnston has been elevated to the position of Principal.
Dr. Johnston, who joined 4BIO Capital in September 2019, has demonstrated valuable contributions in her role as Investment Associate.
Her promotion reflects the recognition of her expertise and dedication within the organization.
The addition of Abbas Hussain and Leszek Lisowski to the Advisory Board enhances 4BIO Capital’s strategic guidance, drawing from their extensive industry experience.
These appointments signal the firm’s commitment to staying at the forefront of advancements in biopharmaceuticals and vector-based gene therapies.
Recognition and Growth
Dr. Natalie Johnston’s promotion to Principal acknowledges her significant contributions to the firm’s investment strategies.
Her elevation reflects 4BIO Capital’s emphasis on recognizing and nurturing talent from within, fostering a culture of growth and expertise development.
About 4BIO Capital
As a venture capital firm with a focus on advanced therapies, 4BIO Capital aims to invest in and support early-stage companies developing treatments in areas with high unmet medical needs.
The firm’s target areas include genomic medicines, cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome.
These appointments and promotions align with the firm’s mission to unlock future treatments and ensure widespread access to transformative therapies.
Strategic Outlook
With these strategic appointments and promotions, 4BIO Capital positions itself for continued success in navigating the evolving landscape of advanced therapies and emerging technologies.
The diverse expertise brought by the Advisory Board and the internal promotion reflect the firm’s commitment to innovation and excellence in the field.
Share on Facebook «||»
Share on Twitter «||»
Share on Reddit «||»
Share on LinkedIn
Governor Ron DeSantis Appoints Chad Poppell to the Florida Faith-Based and Community-Based Advisory Council: Governor Ron DeSantis Appoints Chad Poppell to the Florida Faith-Based and Community-Based Advisory Council TALLAHASSEE, Fla. — Today, Governor Ron DeSantis announced the appointment of Chad...
HiBob Bolsters Human Capital Management with Acquisition of Payroll Solution Provider Pento: Deal Details Remain Confidential The recent acquisition of Pento by HiBob marks a strategic move in the realm of human capital management. While the financial...
Ex-honcho of Wartsila Corporation, Rakesh Sarin, Joins VMentor.ai as Chairman of its Advisory Board: VMentor.ai appoints former Suzlon honcho Rakesh Sarin (Founder Chairman, Wellness Mandala), Blaise Costabir, MD of the Indo-French JV, GMI Zarhak Moulders, and JBIMS Director, Srinivasan...
EAD Secretary General joins Advisory Board of United Nations Decade on Ecosystem Restoration: EAD Secretary General joins Advisory Board of United Nations Decade on Ecosystem Restoration ABU DHABI, 21st February, 2022 – The Environment Agency – Abu Dhabi...
NFL Legend Tom Brady Joins Birmingham Football Club as Advisory Board Chairman: The renowned NFL legend, who recently retired in February, has formed a partnership with Knighthead Capital Management, the new owners of Birmingham Football Club. Advertisement...
Pluristyx Secures Funding Led by BroadOak Capital Partners to Expand iPSC-Based Technologies: Pluristyx, a leading player in the field of induced pluripotent stem cell (iPSC) technologies, has successfully raised a new round of funding. BroadOak Capital Partners...
Cedar Capital, Mumbai-Based Fintech VC Firm, Secures $30 Million in First Close of Early-Stage Fund: Cedar Capital, a prominent fintech venture capital firm headquartered in Mumbai, India, has achieved a significant milestone by securing $30 million in the first close...
New vice-chairperson and board members appointed to Canada’s National Indigenous Economic Development Board: Ottawa, Ontario — Traditional unceded Algonquin Territory — Indigenous Services Canada. Today, the Honourable Patty Hajdu, Minister of Indigenous Services, and Dawn Madahbee Leach, Chair...
A&W Capital Acts as the Exclusive Financial Advisor to CVC Capital Partners on their Winning USD 750 mn Bid for the Ahmedabad IPL Franchise: After CVC’s formal unveiling of the Gujarat Titans yesterday – the new name of the private equity-backed IPL Franchise – A&W Capital is also pleased...
Crypto Trading Platform EDX Markets Raises Substantial Funds in Funding Round Spearheaded by Pantera Capital and Sequoia Capital: Riding the Investment Wave: EDX Markets Secures Substantial Funding from Pantera Capital and Sequoia Capital In a significant financial development, EDX Markets, the digital asset...
